中外健康文摘
中外健康文摘
중외건강문적
WORLD HEALTH DIGEST
2013年
40期
20-21
,共2页
血管紧张素转换酶抑制剂%高血压
血管緊張素轉換酶抑製劑%高血壓
혈관긴장소전환매억제제%고혈압
Angiotensin converting enzyme inhibitors%hypertension
目的:血管紧张素转换酶抑制剂(ACEI)被世界卫生组织和我国《高血压治疗指南》列为一线抗高血压药,ACEI还具有心肾保护作用,可降低各类心血管事件的发生。本文论述了血管紧张素转换酶抑制剂的作用机制、药理特点及临床应用等相关内容,旨在充分发挥药物疗效、提高临床合理用药水平。
目的:血管緊張素轉換酶抑製劑(ACEI)被世界衛生組織和我國《高血壓治療指南》列為一線抗高血壓藥,ACEI還具有心腎保護作用,可降低各類心血管事件的髮生。本文論述瞭血管緊張素轉換酶抑製劑的作用機製、藥理特點及臨床應用等相關內容,旨在充分髮揮藥物療效、提高臨床閤理用藥水平。
목적:혈관긴장소전환매억제제(ACEI)피세계위생조직화아국《고혈압치료지남》렬위일선항고혈압약,ACEI환구유심신보호작용,가강저각류심혈관사건적발생。본문논술료혈관긴장소전환매억제제적작용궤제、약리특점급림상응용등상관내용,지재충분발휘약물료효、제고림상합리용약수평。
Angiotensin converting enzyme inhibitors (ACEI) was listed as first-line antihypertensive drugs by World Health Organization and Chinese journal of hypertension treatment guidelines. ACEI has a heart of renal protective effect, and can reduce the incidence of al kinds of cardiovascular events. This paper discusses the mechanism of action, pharmacological features and clinical application of ACEI, in order to give ful play to the drug efficacy, enhances the level of clinical rational drug use.